Data / Form D filings / Lab21 Ltd
Lab21 Ltd: Form D filing
Lab21 Ltd, a biotechnology company in Cambridge, United Kingdom, filed a Form D with the SEC in 2010. The latest, on October 26, 2010, reports $837,800 sold of a $1.5 million offering to 11 investors.
Find out what Lab21 Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 184 CAMBRIDGE SCIENCE PARK, Cambridge, United Kingdom, CB40G
- Phone
- (864) 751-4815
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- United Kingdom
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1499756
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 26, 2010 | New notice | $1,500,000 | $837,800 | $662,200 | 11 | Oct 15, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael S. Bolick | Executive Officer | |
| Kai T Deusch | Director | |
| Berwyn E Clarke | Executive Officer, Director | |
| Anthony E Atkinson | Director | |
| Edwin T Snape | Director | |
| Christopher T Evans | Director | |
| Susan E Lowther | Executive Officer | |
| Graham D Mullis | Executive Officer, Director |
Every Form D from the week of Oct 25, 2010 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lab21 Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.